Edwards Larry Todd insider trades
Edwards Larry Todd has filed 13 Form 4s with the SEC that we hold, for Arcutis Biotherapeutics, Inc. (ARQT) (See Remarks) and Oruka Therapeutics, Inc. (ORKA) (Chief Commercial Officer). Across all of them we count 1 purchase worth $7.8K and 10 sales worth $1.2M reported on Form 4. In the last 12 months: 0 purchases ($0) and 4 sales ($878.1K). The largest single trade was a sale of 29,131 shares of Arcutis Biotherapeutics, Inc. worth $732.9K, dated 2025-11-06. The first filing on our record is dated 2023-10-03 and the latest 2026-08-25.
Arcutis Biotherapeutics, Inc. (ARQT)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-05-17 | S, sale reported on Form 4 | 7,640 | $68.6K | 2024-05-20 |
| 2024-10-02 | S, sale reported on Form 4 | 3,725 | $37.3K | 2024-10-03 |
| 2024-11-30 | P, purchase reported on Form 4 | 1,093 | $7.8K | 2024-12-03 |
| 2025-02-03 | S, sale reported on Form 4 | 2,173 | $27.6K | 2025-02-04 |
| 2025-05-19 | S, sale reported on Form 4 | 7,451 | $104.8K | 2025-05-20 |
| 2025-10-02 | S, sale reported on Form 4 | 4,207 | $84.1K | 2025-10-06 |
| 2025-10-02 | S, sale reported on Form 4 | 297 | $6.2K | 2025-10-06 |
| 2025-11-06 | S, sale reported on Form 4 | 29,131 | $732.9K | 2025-11-10 |
| 2026-02-02 | S, sale reported on Form 4 | 2,052 | $52.3K | 2026-02-04 |
| 2026-03-02 | S, sale reported on Form 4 | 3,584 | $90.2K | 2026-03-03 |
| 2026-03-02 | S, sale reported on Form 4 | 103 | $2.7K | 2026-03-03 |
Oruka Therapeutics, Inc. (ORKA)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1994805) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms